Thermo Fisher Scientific Inc. (TMO) fundamentals from SEC filings — revenue $44.6B, net margin 15.1%, diluted EPS $17.74 in FY2025. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $39.2B | $44.9B | $42.9B | $42.9B | $44.6B |
| Net income | $7.7B | $7.0B | $6.0B | $6.3B | $6.7B |
| Net margin | 19.7% | 15.5% | 14.0% | 14.8% | 15.1% |
| Diluted EPS | $19.46 | $17.63 | $15.45 | $16.53 | $17.74 |
| Free cash flow | $6.8B | $6.9B | $6.9B | $7.3B | $6.3B |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home